Department of Neurology, Medical College of Wisconsin, Milwaukee, WI, USA.
Neurology. 2012 Sep 25;79(13 Suppl 1):S192-8. doi: 10.1212/WNL.0b013e31826958e3.
Over the past decade, endovascular therapy has emerged as a promising therapeutic approach for select patients with acute ischemic stroke. However, the morbidity, mortality, and complication rates in intra-arterial recanalization trials are higher than in the National Institute of Neurological Disorders and Stroke trial of IV tissue plasminogen activator. This review discusses common complications associated with endovascular therapy for acute ischemic stroke, avoidance of complications, and management of some of the common complications.
在过去的十年中,血管内治疗已成为选择的急性缺血性脑卒中患者有前途的治疗方法。然而,血管内再通试验的发病率、死亡率和并发症发生率高于国家神经疾病和中风研究所 IV 组织型纤溶酶原激活剂试验。本文讨论了急性缺血性脑卒中血管内治疗相关的常见并发症、并发症的预防以及一些常见并发症的处理。